Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
The partnership is the latest in a long line of AI-centric projects in drug discovery and development.
Artificial Intelligence
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?
Oxford University and Ellison Institute link for AI vaccine research
AI psychosis sees users ‘co-creating delusions with technology’ – expert
AI is improving idiopathic pulmonary fibrosis care
Five lessons from biopharma companies’ data transformation journeys
